These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20116383)
1. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury. Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383 [TBL] [Abstract][Full Text] [Related]
2. Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction. Manning JR; Wijeratne AB; Oloizia BB; Zhang Y; Greis KD; Schultz JEJ J Mol Cell Cardiol; 2020 Nov; 148():1-14. PubMed ID: 32853649 [TBL] [Abstract][Full Text] [Related]
3. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. Liao S; Porter D; Scott A; Newman G; Doetschman T; Schultz Jel J J Mol Cell Cardiol; 2007 Jan; 42(1):106-20. PubMed ID: 17150229 [TBL] [Abstract][Full Text] [Related]
4. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction. Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264 [TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920 [TBL] [Abstract][Full Text] [Related]
6. Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection. Burt PM; Xiao L; Doetschman T; Hurley MM J Cell Physiol; 2019 Apr; 234(4):4418-4431. PubMed ID: 30144364 [TBL] [Abstract][Full Text] [Related]
7. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Liao S; Bodmer J; Pietras D; Azhar M; Doetschman T; Schultz Jel J Dev Dyn; 2009 Feb; 238(2):249-64. PubMed ID: 18773489 [TBL] [Abstract][Full Text] [Related]
8. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2. House SL; Melhorn SJ; Newman G; Doetschman T; Schultz Jel J Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H354-65. PubMed ID: 17337596 [TBL] [Abstract][Full Text] [Related]
9. Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. Gaubert F; Escaffit F; Bertrand C; Korc M; Pradayrol L; Clemente F; Estival A J Biol Chem; 2001 Jan; 276(2):1545-54. PubMed ID: 11031252 [TBL] [Abstract][Full Text] [Related]
11. Gene targeted ablation of high molecular weight fibroblast growth factor-2. Azhar M; Yin M; Zhou M; Li H; Mustafa M; Nusayr E; Keenan JB; Chen H; Pawlosky S; Gard C; Grisham C; Sanford LP; Doetschman T Dev Dyn; 2009 Feb; 238(2):351-7. PubMed ID: 19105223 [TBL] [Abstract][Full Text] [Related]
12. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro. Xiao L; Esliger A; Hurley MM J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867 [TBL] [Abstract][Full Text] [Related]
13. High molecular weight FGF2 isoforms demonstrate canonical receptor-mediated activity and support human embryonic stem cell self-renewal. Kole D; Grella A; Dolivo D; Shumaker L; Hermans W; Dominko T Stem Cell Res; 2017 May; 21():106-116. PubMed ID: 28433654 [TBL] [Abstract][Full Text] [Related]
14. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury. House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503 [TBL] [Abstract][Full Text] [Related]
15. Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma. Andreucci E; Bianchini F; Biagioni A; Del Rosso M; Papucci L; Schiavone N; Magnelli L J Mol Med (Berl); 2017 Jan; 95(1):97-108. PubMed ID: 27558498 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade. House SL; Branch K; Newman G; Doetschman T; Schultz Jel J Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2167-75. PubMed ID: 16040717 [TBL] [Abstract][Full Text] [Related]
17. Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model. Wijeratne AB; Manning JR; Schultz Jel J; Greis KD J Proteome Res; 2013 Oct; 12(10):4268-79. PubMed ID: 24016359 [TBL] [Abstract][Full Text] [Related]
18. Cardiac mTOR protects the heart against ischemia-reperfusion injury. Aoyagi T; Kusakari Y; Xiao CY; Inouye BT; Takahashi M; Scherrer-Crosbie M; Rosenzweig A; Hara K; Matsui T Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H75-85. PubMed ID: 22561297 [TBL] [Abstract][Full Text] [Related]
19. Effect of overexpressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cells. Xiao L; Liu P; Sobue T; Lichtler A; Coffin JD; Hurley MM J Cell Biochem; 2003 Aug; 89(6):1291-301. PubMed ID: 12898525 [TBL] [Abstract][Full Text] [Related]
20. Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis. Homer-Bouthiette C; Doetschman T; Xiao L; Hurley MM J Biol Chem; 2014 Dec; 289(52):36303-14. PubMed ID: 25389287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]